BVMF/MRCK34 (BVMF/MRCK34)

Brazil Stock Exchange: BVMF/MRCK34 · BRL

R$94.4

-0.28 (-0.3%)· Recorded snapshot

Market cap	1.9T
Revenue (ttm)	344.9B
Net income (ttm)	16.4B
EPS (ttm)	R$0.85
P/E (trailing)	110.8x
P/E (forward)	16.8x
Dividend	R$1.43 (1.52%)
Volume	12,517
Beta	0.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 344.9B
Net income (ttm): 16.4B
EPS (ttm): R$0.85
P/E (trailing): 110.8x
P/E (forward): 16.8x
Market cap: 1.9T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.8

P25 n/aP50 n/aP75 n/a

Trailing P/E110.8

P25 n/aP50 n/aP75 n/a

ROE7

P25 n/aP50 n/aP75 n/a

ROIC14.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/MRCK34 indicators

Market & fundamental data

Available fields

249

Groups with data

Currency

USD

Showing 249 of 249 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-29
Employees	75,000
Employees change	0
Employees growth	0%
Enterprise value	BRL 2.1T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1891
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRMRCKBDR003
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2020-10-29
Last stock split type	Forward
Market cap	BRL 1.9T
Next earnings date	2026-10-29
Price	BRL 94.35
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bvmf/MRCK34
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	56.04x
Average P/E ratio (3Y)	100.29x
Average P/E ratio (5Y)	71.09x
Earnings yield	0.9%
EV/Earnings	129.04x
EV/EBIT	16.89x
EV/EBITDA	13.54x
EV/FCF	25.49x
EV/Sales	5.96x
FCF / EV yield	3.92%
FCF yield	4.45%
Forward P/E	16.83x
Graham number	14.32682
Graham upside	-84.84%
Lynch fair value	BRL 4.15
Lynch upside	-95.61%
P/(FCF - SBC) ratio	23.8x
P/(OCF - SBC) ratio	18.93x
P/B ratio	8.6x
P/E ratio	110.8x
P/FCF ratio	22.48x
P/OCF ratio	18.09x
P/S ratio	5.42x
Price/EBITDA ratio	12.51x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.28%
EBITDA margin	43.37%
Effective tax rate	46.72%
FCF margin	23.36%
Gross margin	75.9%
Operating margin	35.28%
Pretax margin	8.94%
Profit margin	4.77%
Profit per employee	BRL 222,144
Profitable years	35
Revenue per employee	BRL 4.7M
ROA	11.87%
ROA (5Y)	11.18%
ROCE	23.01%
ROE	6.96%
ROE (5Y)	30.37%
ROIC	14.05%
ROIC (5Y)	22.36%
SBC / revenue	1.34%
Tax / revenue	4.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-80.37%
EPS growth 10Y	-3.53%
EPS growth 3Y	1.25%
EPS growth 5Y	-10.38%
EPS growth years	2
FCF growth	9.11%
FCF growth (Q)	77.03%
FCF growth (QoQ)	52.96%
FCF growth 3Y	14.05%
FCF growth 5Y	18.23%
Gross profit growth	2.6%
Gross profit growth (Q)	0.52%
Gross profit growth 3Y	5.77%
Gross profit growth 5Y	9.69%
Net income growth	-80.66%
Net income growth 3Y	0.66%
Net income growth 5Y	-10.64%
Net income growth years	2
OCF growth	7.73%
OCF growth (Q)	63.07%
OCF growth (QoQ)	37.06%
OCF growth 10Y	5.83%
OCF growth 3Y	9.82%
OCF growth 5Y	10.91%
Operating income growth	-1.53%
Operating income growth 3Y	5.7%
Operating income growth 5Y	13.81%
Revenue growth	4.64%
Revenue growth (Q)	5.07%
Revenue growth (QoQ)	1.97%
Revenue growth 10Y	5.37%
Revenue growth 3Y	4.51%
Revenue growth 5Y	8.68%
Revenue growth quarters	4
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -20.2B
Depreciation and amortization	BRL 28.8B
EBIT	BRL 121.7B
EBITDA	BRL 149.6B
EPS	BRL 0.85
Financing cash flow	BRL 32B
Free cash flow	BRL 83.2B
Free cash flow minus SBC	BRL 78.6B
Gross profit	BRL 261.8B
Income taxes	BRL 14.4B
Investing cash flow	BRL -141.4B
Net borrowing	BRL 100B
Net cash flow	BRL -6.1B
Net income	BRL 16.4B
Operating cash flow minus SBC	BRL 98.8B
Operating income	BRL 121.7B
Revenue	BRL 344.9B
Stock-based compensation	BRL 4.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.6
Book value per share	BRL 88.00
Debt / EBITDA	1.84
Debt / equity	1.28
Debt / FCF	3.36
Goodwill	BRL 115.5B
Interest coverage	13.47
Long-term assets	BRL 476.2B
Long-term liabilities	BRL 306.6B
Net cash (debt)	BRL -242.3B
Net cash / market cap	-12.95%
Net debt / EBITDA	1.62
Net debt / equity	1.11
Net debt / FCF	2.91
Piotroski F-Score	4
Property, plant and equipment	BRL 137.7B
Shareholders' equity	BRL 217.5B
Tangible book value	BRL -24B
Tangible book value per share	BRL -9.71
Total assets	BRL 672.5B
Total cash	BRL 37B
Total debt	BRL 279.3B
Total liabilities	BRL 455B
WACC	4.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	BRL 196.3B
Current liabilities	BRL 148.4B
Current ratio	1.32
Inventory turnover	2.51
Net working capital	BRL 24B
Quick ratio	0.74
Working capital	BRL 46.4B
Working capital turnover	34.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.92%
Dividend growth	2.67%
Dividend growth (10Y)	6.46%
Dividend growth (3Y)	4.59%
Dividend growth (5Y)	4.33%
Dividend growth years	10
Dividend payment date	2026-10-14
Dividend payment years	17
Dividend payout frequency	Quarterly
Dividend per share	BRL 1.43
Dividend yield	1.52%
Ex-dividend date	2026-09-14
Last dividend	BRL 0.07
Payout ratio	261.52%
Shareholder yield	3.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	295.8%
10Y return CAGR	17.13%
10Y total return	385.79%
150-day SMA	BRL 82.85
1D price change	-0.3%
1M price change	-4.72%
1M total return	-4.72%
1W price change	6.13%
1W total return	6.13%
1Y price change	60.02%
1Y return CAGR	63.21%
1Y total return	63.15%
20-day SMA	BRL 92.12
200-day SMA	BRL 80.99
3M price change	13.14%
3M total return	13.58%
3Y price change	42.8%
3Y return CAGR	14.92%
3Y total return	51.8%
50-day SMA	BRL 94.41
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 101.38
52-week high date	2026-08-26
52-week low	BRL 55.23
52-week low date	2025-11-03
5Y price change	64.89%
5Y return CAGR	12.81%
5Y total return	82.66%
6M price change	34.75%
6M total return	35.92%
All-time high	BRL 101.38
All-time high date	2026-08-26
All-time low	BRL 8.83
All-time low date	2011-12-28
Average true range (ATR)	BRL 3.85
Average volume	3.5K
Beta (5Y)	0.22
Change from 52-week high	-6.93%
Change from 52-week low	70.83%
Change from all-time high	-6.93%
Change from all-time low	968.52%
Change from open	0.1%
Day's gap	-0.39%
Dollar volume	BRL 1.2M
High price	BRL 95.39
Low price	BRL 93.37
Monthly RSI	65.77
Open price	BRL 94.26
Position in 52-week range	48.51%
Previous close	BRL 94.63
Price vs 150-day SMA	13.88%
Price vs 20-day SMA	2.43%
Price vs 200-day SMA	16.49%
Price vs 50-day SMA	-0.06%
Relative volume	3.54
RSI	53.13
Sharpe ratio	1.43
Sharpe ratio (3Y)	0.47
Sharpe ratio (5Y)	0.42
Sortino ratio	2.52
Sortino ratio (3Y)	0.89
Sortino ratio (5Y)	0.81
Volume	12.5K
Weekly RSI	59.47
YTD price change	29.02%
YTD total return	30.77%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.5B
Shares change (QoQ)	-0.08%
Shares change (YoY)	-1.92%
Shares held by insiders	0.05%
Shares held by institutions	81.18%
Short ratio	2.6 days

Deeper analysis on BVMF/MRCK34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/MRCK34 report

Is a complete BVMF/MRCK34 research report available?

No complete published report is available for bvmf/MRCK34 (BVMF/MRCK34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/MRCK34 (BVMF/MRCK34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/MRCK34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/MRCK34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/MRCK34

Frequently asked questions